A partnership between AI specialist Owkin and drugmaker AstraZeneca has been formed to find tools that can be applied to digitised pathology slides, acting as a 'pre-screen' for BRCA mutations ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

AION was created through an alliance of four pharma companies, AstraZeneca ... The company recently made an investment in AI-focused Owkin, with the goal of discovering new biomarkers and ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of lung cancer, a step that will delay the drug’s arrival on the ...

AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of $3.5 billion announced to bolster research and manufacturing. AstraZeneca ...

London: British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that led to ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine research and development ...

AstraZeneca has put a £450m investment in Britain under review in a stand-off with ministers over state aid. The drugs giant told The Telegraph that proposals to build a new vaccine factory in ...

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price. Chief ...

Deep-pocketed investors have adopted a bullish approach towards AstraZeneca AZN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...